People · Operator
Named in public records as an officer, director or promoter · active 2013–2015 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Biotie Therapies Corp. | — | Pharmaceuticals | Series D+ | $149.8M | $214.0M | 2013 |
Timo Veromaa at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Timo Veromaa on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| DAVID COOK | 1 | 5 |
| William Burns | 1 | 3 |
| Mahendra G. Shah | 1 | 3 |
| Guido Magni | 1 | 3 |
| ISMAIL KOLA | 1 | 2 |
| Ian Massey | 1 | 2 |
| Williams Burns | 1 | 1 |
| Peter Fellner | 1 | 1 |
| Merja Karhapaa | 1 | 1 |
| Don Matthew Bailey | 1 | 1 |
| Bernd Kastler | 1 | 1 |
| Medhi Paborji | 1 | 1 |
| Stephen Bandak | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.